XM does not provide services to residents of the United States of America.
D
D

DentsplySirona

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Bath & Body Works, Datadog, Savers Value Village

U.S. RESEARCH ROUNDUP-Bath & Body Works, Datadog, Savers Value Village Nov 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bath & Body Works, Datadog and Savers Value Village, on Friday. HIGHLIGHTS * Bath & Body Works Inc BBWI.N : Barclays cuts to underweight from equal weight * Datadog Inc DDOG.O : Monness Crespi Hardt raises to buy from neutral * Montrose Environmental Group Inc MEG.N : JP Morgan cuts to neutral
A
C
F
H
M
D
A
D
L
A
A
C
C

U.S. STOCKS BorgWarner, Digital Realty, Take-Two

BUZZ-U.S. STOCKS ON THE MOVE-BorgWarner, Digital Realty, Take-Two Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes added to their gains on Thursday in the run-up to the Federal Reserve's interest-rate decision, extending a sharp rally sparked by Donald Trump's stunning comeback as U.S.
G
H
J
M
M
N
D
T
U
U
B
L
V
A
B
C
M

U.S. STOCKS Ralph Lauren, CoreCivic, WK Kellogg

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, CoreCivic, WK Kellogg Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes held on to their gains on Thursday in the run-up to the Federal Reserve's interest-rate decision, extending a sharp rally sparked by Donald Trump's stunning comeback as U.S.
G
H
J
K
M
D
U
U
B
M
V
A
C
M

Dentsply Sirona sinks after company lowers annual profit forecast

BUZZ-Dentsply Sirona sinks after company lowers annual profit forecast ** Dental products maker Dentsply Sirona's XRAY.O shares fall 19.1% to $19.41, lowest in more than 2 decades ** Company forecasts annual adj profit per share between $1.82 and $1.86, down from its prior forecast range of $1.96 to $2.02 ** Dentsply says forecast cut due to volunt
D

DENTSPLY SIRONA Inc reports results for the quarter ended in September 30 - Earnings Summary

DENTSPLY SIRONA Inc reports results for the quarter ended in September 30 - Earnings Summary DENTSPLY SIRONA Inc XRAY.OQ reported quarterly adjusted earnings of 50 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 49 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 47 cents per share.
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.